Day after Goa prescribes Ivermectin as prophylaxis for Covid-19, WHO chief scientist recommends against it
In March, too, the WHO had recommended that the drug ivermectin only be used within clinical trials.
The court also noted that the government had decided to use it for suspected and symptomatic patients according to the affidavit submitted. (Representational image) A day after Goa prescribed Ivermectin for all those above the age of 18, Chief Scientist at the World Health Organization (WHO) Dr Soumya Swaminathan Tuesday said the global body recommends against the use of the drug, except within clinical trials.
“Safety and efficacy are important when using any drug for a new indication. WHO recommends against the use of ivermectin for #COVID19 except within clinical trials,” Dr Swaminathan tweeted.
She attached a press released by German healthcare company Merck, dated February 4, which said its scientists were still examining the findings of ivermectin for the treatment of Covid-19.
Merck said its analysis had, till date, found (i) No scientific basis for a potential therapeutic effect against Covid-19 from pre-clinical studies; (ii) No meaningful evidence for clinical activity or clinical efficacy in patients with Covid-19 disease, and; (iii) A concerning lack of safety data in the majority of studies.
Share
